Publish to Newswire
Add an EventAdd Comment on:
Student AIDS Activists Applaud Breakthrough in Gilead’s Policies on AIDS Drugs for Global
The Student Global AIDS Campaign (SGAC) is applauding what it calls “important steps forward and major new promises” taken by Gilead in making its AIDS drugs Tenofovir (Viread) and Truvada affordable and available in Africa and the global South. The Student Global AIDS Campaign—a national network of AIDS activists in high schools and colleges—has been running a campaign focused on Gilead since this winter. That campaign has engaged students from across the country in asking the company to rectify the current situation in which the vast majority of people living with HIV in the world do not have access to Gilead’s AIDS drugs.
The Student Global AIDS Campaign (SGAC) is applauding what it calls “important steps forward and major new promises” taken by Gilead in making its AIDS drugs Tenofovir (Viread) and Truvada affordable and available in Africa and the global South. The Student Global AIDS Campaign—a national network of AIDS activists in high schools and colleges—has been running a campaign focused on Gilead since this winter. That campaign has engaged students from across the country in asking the company to rectify the current situation in which the vast majority of people living with HIV in the world do not have access to Gilead’s AIDS drugs.
×
Previews not available for media files.
Short description of the image used by screen readers.
Guidelines for commenting on news articles:
Thanks for contributing to Indybay's open publishing newswire. You may use any format for your response, from traditional academic discourse to subjective personal account. Please, keep it on topic and concise. Read our editorial policy, privacy, and legal statements before continuing. Or go back to the article.